HEALWELL's Pentavere Receives Prestigious Prix Galien USA 2024 Award for Best Digital Health Startup for Its Contributions in AI for Life Sciences Industry

In This Article:

  • The Prix Galien Award is among the global health innovation industry's most renowned honors, recognizing outstanding biomedical, medical, and technology achievements that improve the human condition and is considered the industry's equivalent of the Nobel Prize.

  • Pentavere's DARWEN™ AI platform was awarded for its proven contribution in making healthcare more accessible and personalized for patients and for using various forms of AI including generative AI to help identify patients and detect disease on a preventative basis.

  • The Prix Galien selection committee that selected Pentavere to be the recipient of this award was comprised of current and former Chief Executive Officers of some of the world's largest life science companies. This was the first win for Pentavere after three nominations in previous years.

Toronto, Ontario--(Newsfile Corp. - November 12, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce that its subsidiary, Pentavere Research Group ("Pentavere"), a globally recognized AI digital health company, has been awarded by the Galien Foundation, The Prix Galien USA 2024 prize in the Best Startup category for Digital Health & Medical Technology. Pentavere's DARWEN™ AI platform was awarded for its proven contribution in making healthcare more accessible and personalized for patients. Pentavere was selected as one of two recipients from a total of 43 nominees in the Best Startup category.

Aaron Leibtag, CEO and Co-Founder of Pentavere, commented, "We are honored to receive this prestigious award from The Galien Foundation in recognition of our best-in-class DARWEN™ AI platform for the impact it is having for providers and patients. At Pentavere, we envision that using AI to fully understand the entire patient journey at scale could be as transformative as decoding the human genome. Receiving a Prix Galien award by a panel of some of the most respected global thought leaders from across the life science industry validated the enormity of our AI work to improve the human condition."

The Prix Galien Award is among the global health innovation industry's most renowned honors, recognizing outstanding biomedical and medical technology product achievements that improve the human condition. The award was presented during a ceremony at the American Museum of Natural History in New York on Thursday, November 7, 2024. This was the first win for Pentavere after three nominations in previous years.